or Try an Advanced Search...

    Technical Analysis for TSVT - 2seventy bio, Inc.

    Grade Last Price % Change Price Change
    C 4.46 -0.45% -0.02
    TSVT closed down 9.68 percent on Wednesday, May 8, 2024, on 59 percent of normal volume. The stock fell below its 50 day moving average, damaging its intermediate-term outlook by crossing under that important trendline.
    2 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Up Down Down
    Historical TSVT trend table...
    Date Alert Name Type % Chg
    Fell Below 20 DMA Bearish -0.45%
    Fell Below 50 DMA Bearish -0.45%
    Bollinger Band Squeeze Range Contraction -0.45%
    Earnings Movers Other -0.45%
    BB Squeeze Started Range Contraction -0.45%
    Overbought Stochastic Strength -0.45%
    50 DMA Support Bullish -10.08%
    NR7 Range Contraction -10.08%
    Narrow Range Bar Range Contraction -10.08%
    Overbought Stochastic Strength -10.08%
    Older End-of-Day Signals for TSVT ...

       Recent Intraday Alerts

    Alert Time
    200 DMA Support about 3 hours ago
    Down 3% about 3 hours ago
    Up 1% about 3 hours ago
    Down 2 % about 4 hours ago
    Fell Below Previous Day's Low about 4 hours ago
    View Earlier Intraday Alerts

    Free Daily (Stock) Chart Reading

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    TSVT Chart by TradingView
    Basic chart:

    Profile

    2seventy bio, Inc., a cell and gene therapy company, focuses on the research, development, and commercialization of treatments for cancer in the United States. Its products pipeline includes idecabtagene vicleucel; ide-cel or Abecma and bb21217; and CAR-T cell product candidates for the treatment of multiple myeloma. 2seventy bio, Inc. has a collaboration arrangement with Bristol-Myers Squibb Company. The company was incorporated in 2021 and is headquartered in Cambridge, Massachusetts. 2seventy bio, Inc. operates independently of bluebird bio, Inc. as of November 4, 2021.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Medicine Cancer Life Sciences Gene Therapy Multiple Myeloma Breakthrough Therapy Chimeric Antigen Receptor T Cell

    Is TSVT a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 1 bullish, 1 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    May 8 2seventy bio, Inc. (TSVT) Q1 2024 Earnings Call Transcript
    May 8 2seventy bio GAAP EPS of -$1.01 misses by $0.20, revenue of $12.4M misses by $1.69M
    May 8 2seventy bio Reports First Quarter Financial Results and Recent Operational Progress
    May 7 2seventy bio Q1 2024 Earnings Preview
    May 3 2seventy bio to Report First Quarter 2024 Financial Results on May 8, 2024
    Apr 25 Bristol-Myers posts Q1 beat despite growth headwinds
    Apr 5 Bristol Myers, 2seventy bio's Abecma approved for earlier line multiple myeloma
    Apr 5 U.S. FDA Approves Bristol Myers Squibb and 2seventy bio’s Abecma for Triple-Class Exposed Relapsed or Refractory Multiple Myeloma After Two Prior Lines of Therapy
    Apr 3 2seventy Bio: Maximizing ABECMA's Potential To Fuel A Turnaround
    Apr 1 2seventy bio Announces Completion of Oncology and Autoimmune Pipeline Divestiture to Regeneron
    See more TSVT news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 12.69
    52 Week Low 1.535
    Average Volume 1,191,473
    200-Day Moving Average 4.36
    50-Day Moving Average 4.90
    20-Day Moving Average 4.73
    10-Day Moving Average 4.64
    Average True Range 0.42
    RSI (14) 44.44
    ADX 15.19
    +DI 22.06
    -DI 28.11
    Chandelier Exit (Long, 3 ATRs) 4.54
    Chandelier Exit (Short, 3 ATRs) 4.71
    Upper Bollinger Bands 5.34
    Lower Bollinger Band 4.11
    Percent B (%b) 0.3
    BandWidth 25.95
    MACD Line -0.07
    MACD Signal Line -0.09
    MACD Histogram 0.0241
    Fundamentals Value
    Market Cap 226.8 Million
    Num Shares 50.6 Million
    EPS -3.77
    Price-to-Earnings (P/E) Ratio -1.19
    Price-to-Sales 2.08
    Price-to-Book 0.99
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 5.40
    Resistance 3 (R3) 5.49 5.28 5.24
    Resistance 2 (R2) 5.28 5.05 5.23 5.19
    Resistance 1 (R1) 4.88 4.90 4.78 4.79 5.14
    Pivot Point 4.67 4.67 4.62 4.62 4.67
    Support 1 (S1) 4.27 4.44 4.17 4.18 3.82
    Support 2 (S2) 4.06 4.29 4.01 3.77
    Support 3 (S3) 3.66 4.06 3.72
    Support 4 (S4) 3.57